The endocannabinoid system and its therapeutic exploitation
The DOI matches its Crossref record; 160 of the 161 references it cites were found in a registry or an index.
Abstract
The term 'endocannabinoid' - originally coined in the mid-1990s after the discovery of membrane receptors for the psychoactive principle in Cannabis, Delta9-tetrahydrocannabinol and their endogenous ligands - now indicates a whole signalling system that comprises cannabinoid receptors, endogenous ligands and enzymes for ligand biosynthesis and inactivation. This system seems to be involved in an ever-increasing number of pathological conditions. With novel products already being aimed at the pharmaceutical market little more than a decade since the discovery of cannabinoid receptors, the endocannabinoid system seems to hold even more promise for the future development of therapeutic drugs. We explore the conditions under which the potential of targeting the endocannabinoid system might be realized in the years to come.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The obvious implications are that cannabinoids and similarly acting drugs may regulate cognitive functions, modulate food intake, affect both female and male reproduction, provide neuroprotection and be involved in neurodegenerative diseases; pathophysiology of shock; inhibition of fertilized oocyte implantation; inhibition of cancer growth, angiogenesis and metastasis (for a review see ref. 71).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [71]
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · cited 1×
“∆(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB1 receptor antagonist/inverse agonist SR 141716A Neuropsychopharmacology 24, 198–203 (2001).”
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · cited 1×
“The serendipitous cloning in 1990 of the first of such proteins, the CB 1 receptor, came from the screening of an 'orphan' G-protein-coupled receptor (GPCR) with several possible ligand”
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 1×
“1 ), led to the identification of plasma membrane CANNABINOID RECEPTORS in 1988 (Ref”
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · cited 1×
“Functions of the endocannabinoid system The components ( Figs 3 , 4 ) and possible physiological functions of the endocannabinoid system have been extensively reviewed in recent article”
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Research works printed but not linked: 4
- Mechoulam, R. in Cannabis as Therapeutic Agent (ed. Mechoulam, R.) 1–19 (CRC Press Roca Ranton, 1986). The most comprehensive history of the recreational and medicinal use of Cannabis throughout the centuries.
- Di Marzo, V., Bisogno, T., De Petrocellis, L., Berger, A. & Mechoulam, R. in Biology of Marijuana (ed. Onaivi, E.) 125–173 (Harwood Academic, Reading, 2002).
- Pertwee, R. G. in Cannabinoids (ed. Di Marzo, V.) 32–83 (Kluwer Academic, New York, 2004).
- Pop, E. Dexanabinol Pharmos. Curr. Opin. Investig. Drugs 1, 494–503 (2000).
Cited by
Items 901–1,000 of 1,001
Srinivasan, G., & Shukla, D. (2024) · INDIAN DRUGS · doi:10.53879/id.61.10.14528 · Cited by 2
Iden, J. A., Ben‐Califa, N., Naim, A., Liron, T., Neumann, D., & Gabet, Y. (2025) · Oncogene · doi:10.1038/s41388-025-03399-9 · Cited by 2
“An emerging therapeutic target is the endocannabinoid system, comprising endogenous lipids, enzymes, and receptors, including cannabinoid receptor 2 (CB2) [3 – 5].”
Low Abuse Potential of Plant-Derived Highly Purified Cannabidiol: A Narrative Review
Yamamoto, H., Dayal, S., Nortvedt, C., & Takumi, I. (2025) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.25-00086 · Cited by 2
COVID-19 is Associated with a Lipid Storm that Worsens in Cases of Severe Pneumonia
Bouabdallah, A., Fradj, M. K. B., Hammami, M. B., Abdelmalek, R., Sanhaji, H., Klopfenstein, T., & Feki, M. (2025) · Microorganisms · doi:10.3390/microorganisms13112622 · Cited by 2
“The synthesis of eCBs occurs on demand as an adaptive response to counteract the insult/injury and restore homeostasis [8].”
Strnad, O., Nejedlý, T., Svoboda, P., Mertlíková‐Kaiserová, H., Malý, M., Malý, M., Stranska-Zachariasova, M., & Viktorová, J. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.121134 · Cited by 2
Corallo, A. A., Noli, C., Brizzi, A., Paolino, M., Mugnaini, C., & Corelli, F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020573 · Cited by 2
“Owing to its multifaceted functions and its capacity to fine-tune neuronal and systemic responses, the ECS represents an attractive and versatile pharmacological target, with potential therapeutic applications in a wide spectrum of pathological states [65].”
Riahi, A., Lansari, R., Fradj, M. K. B., Flah, W. B., Hkimi, K., Emna, B., Melki, W., & Feki, M. (2026) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2026.102734 · Cited by 2
The interplay between bile acid metabolism and gut microbiome in biliary tract cancers
Ike, I., Teymouri, F., Crook, C. J., Guzman, S., Hazeltine, M. D., Castillo, D., Li, D., & Brar, G. (2026) · Frontiers in Microbiomes · doi:10.3389/frmbi.2026.1774429 · Cited by 2
Couttas, T. A., Hoffmann, A., Jieu, B., Golla, F. R., Shepherd, C. E., Leweke, F. M., & Rohleder, C. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04120-4 · Cited by 2
Komaki, A., Haghgooyan, A., Shahidi, ., Sarihi, A., & Salehi, I. (2014) · Avicenna Journal of Neuro Psych Physiology · doi:10.17795/ajnpp-24450 · Cited by 2
“The Ca2+ influx is a necessary step in both neurotransmitter release and synthesis of endocannabinoids (72).”
BackgroundAndreuccetti, G., Ye, Y., Kang, J., Korcha, R. A., Witbrodt, J., Carvalho, H. B., & CHERPITEL, C. J. S. (2017) · Contemporary Drug Problems · doi:10.1177/0091450917710763 · Cited by 2
Research Progress of Itch Signal Pathways and Related Receptors
Yang, Y. T., & Tang, Z. (2013) · ACTA AGRONOMICA SINICA · doi:10.3724/sp.j.1206.2012.00400 · Cited by 2
Ragusa, G., Bencivenni, S., Morales, P., Callaway, T., Hurst, D. P., Asproni, B., Merighi, S., Loriga, G., Pinna, G. A., Reggio, P. H., et al. (2018) · ChemMedChem · doi:10.1002/cmdc.201800152 · Cited by 2
Sermsaksasithorn, P., Nopsopon, T., Samuthpongtorn, C., Chotirosniramit, K., & Pongpirul, K. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-075007 · Cited by 2
“the treatment of chemotherapy-induced nausea and vomiting in cancer patients [8-11].”
BackgroundLong-term Effects of Cannabidiol and/or Fentanyl Exposure in Rats Submitted to Neonatal Pain
Rêgo, D. B., Calió, M. L., Filev, R., Mello, L. E., & Leslie, A. T. F. S. (2023) · Journal of Pain · doi:10.1016/j.jpain.2023.10.001 · Cited by 2
Dudek, K., Paton, S. E. J., Collignon, A., Lebel, M., Lavoie, O., Bouchard, J., Kaufmann, F. N., Dion‐Albert, L., Clavet-Fournier, V., Binder, L. B., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.02.012 · Cited by 2
Self-citationCannabidiol in experimental cerebral ischemia
de Oliveira, R. M. W., Kohara, N. A. N., & Milani, H. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.04.012 · Cited by 2
Jeong, Y. Y., Yoo, J. H., Jeong, S. Y., Lee, M.-H., Park, S. J., Lim, N. Y., Son, S. W., Han, K., & Woo, D. H. (2024) · iScience · doi:10.1016/j.isci.2024.111069 · Cited by 2
Jiang, B., He, Y., Chen, J., Jiang, X.-W., Qiu, Z.-L., Liang, Q.-W., Gao, X.-L., Zhang, H., Tian, H.-G., Liu, M., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117117 · Cited by 2
Tan, Y., Xia, H., & Song, Q. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1540619 · Cited by 2
PET Molecular Imaging of the Endocannabinoid System in Psychiatric Disorders
Cui, C., Dou, X., Cen, P., Jin, C., Wang, J., Niu, J., Xue, C., Tian, M., Zhang, H., & Zhong, Y. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01515-z · Cited by 2
“This activation facilitates various signal transduction pathways, including adenylyl cyclase inhibition and ion channel modulation [40].”
La marihuana y sus derivados en el manejo del dolor crónico
Granados Soto, V., & Islas-Espinoza, A. M. (2022) · Milenaria Ciencia y arte · Cited by 2
Modification of Cardiometabolic Risk Through Cannabinoid Type-1 Receptor Antagonism
Andrikopoulos, G. K., & Tzeis, S. M. (2008) · Angiology · doi:10.1177/0003319708320938 · Cited by 2
“The endocannabinoid system consists of 2 major receptor groups, the CB1 and CB2 receptors and their ligands, mainly the endogenous lipids anandamide and 2-arachidonoyl-glycerol (2-AG).(12,13) The cannabinoid receptors are G-protein-coupled receptors located centrally, mainly in hypothalamic nuclei and in the mesolimbi…”
BackgroundEndocannabinoids in the pathophysiology of obesity – The liver
Mallat, A., & Lotersztajn, S. (2010) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2010.11.001 · Cited by 2
Pharmacological management of obesity: Past, present and future
Habibuddin, M., & Humaira, T. (2014) · Saudi Journal of Obesity · doi:10.4103/2347-2618.137568 · Cited by 2
Endocannabinoids and Energy Homeostasis
Woods, S. C., & Cota, D. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-400-1_3 · Cited by 2
“This model of EC synthesis, action, and degradation has been described as an “on demand” process that is utilized by neurons mainly during periods of high-frequency membrane stimulation ( 28 ) or sudden bursts of Chapter 3 / Endocannabinoids 53”
BackgroundAlmestrand, S., Wang, X., Jeppsson-Ahlberg, Å., Nordgren, M., Flygare, J., Christensson, B., Rössner, S., & Sander, B. (2015) · PeerJ · doi:10.7717/peerj.1056 · Cited by 2
“…20 May 2015) 47 Introduction 48 49 The endocannabinoid system consists of the cannabinoid type 1 (CB1) and cannabinoid type 2 50 (CB2) receptors, their endogenous ligands anandamide and 2-arachidonoyl glycerol and the 51 enzymes involved in their biosynthesis and metabolism (Di Marzo et al. 2004).”
BackgroundWeight-reducing drug therapy and hypertension
Schimkus, J., & Scholze, J. (2008) · Therapy · doi:10.2217/14750708.5.6.779 · Cited by 2
Grimaldi, C., & Bifulco, M. (2007) · Cited by 2
Self-citationGaal, L. F. V., & Després, J. (2008) · Cited by 2
Cannabis, Migration, and Psychosis Onset
Kokona, A., Tarricone, I., Forti, M. D., & Carra, E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00010-7 · Cited by 2
Is the Use of Cannabis During Pregnancy a Risk Factor for Autism?
Crawford, S. (2019) · Autism - Open Access · doi:10.35248/2165-7890.19.9.245 · Cited by 2
“CB1 activation leads to a decrease in cyclic adenosine monophosphate (cAMP), inhibition of cAMPdependent protein kinase (PKA), and stimulation of mitogenactivated protein kinase (MAPK), which influences cell migration, neuronal growth and synaptic plasticity [2-5].”
BackgroundGaudette, E. V., Watling, S. E., Warsh, J. J., McCluskey, T., Tong, J., Houle, S., Rusjan, P., Rhind, S. G., Bazinet, R. P., Tyndale, R. F., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.729 · Cited by 2
Osório, J. H., & Hernandez, C. J. V. (2019) · Biosalud · doi:10.17151/biosa.2019.18.1.2 · Cited by 2
Neuroprotective Effects of Cannabidiol Under Cerebral Ischemic Conditions
Meyer, E., de Mattos, B. A., Kirchhoff, F., & de Oliveira, R. M. W. (2021) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-021-00199-6 · Cited by 2
The Effect of Endocannabinoid System on Energy Metabolism and Obesity
Alphan, E. T., & Yılmaz, N. (2007) · Dspace Repository (Marmara Üniversitesi) · Cited by 2
EXPLORING THE EFFICACY AND SAFETY OF CANNABIS IN THE MANAGEMENT OF FIBROMYALGIA
Sagdeo, A., Askari, A., Ball, P., & Morrissey, H. (2022) · International Journal of Current Pharmaceutical Research · doi:10.22159/ijcpr.2022v14i1.44109 · Cited by 2
“Endocannabinoids are believed to modulate nociceptive sensory pathways and alter pain perception in chronic pain states [19, 20].”
BackgroundLara‐Celador, I., Goñi‐de‐Cerio, F., Alvarez, A. A., & Hilario, E. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.08.008 · Cited by 2
“Moreover, some studies have also reported the interaction of anandamide with both muscarinic [109] and serotonergic receptors [110] .”
BackgroundKnowledge of Good and Evil: An Urban Ethnography of a Smoking Culture
Cathcart, J. H. (2016) · eScholarship (California Digital Library) · Cited by 2
Jaisswar, C. (2020) · Lancaster EPrints (Lancaster University) · doi:10.17635/lancaster/thesis/1040 · Cited by 2
Ignatowska-Jankowska, B. M., Özer, A. G., Kuck, A., Niphakis, M. J., Ogasawara, D., Cravatt, B. F., & Uusisaari, M. Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.25.546437 · Cited by 2
(2021) · Oxford University Press eBooks · doi:10.1093/med/9780197534052.005.0004 · Cited by 2
Maurel, S. (2024) · theses.fr (ABES) · doi:10.70675/f3a2932cz273fz47adzb18cz58f50bf2e53d · Cited by 2
Breunig, E. (2010) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3191 · Cited by 2
Nickl, K. (2008) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.10750 · Cited by 2
Endocannabinoid system and eating behavior / Sistema endocannabinoide y conducta alimentaria
Ramírez-Emiliano, J., Ortega-Barrón, I. G., Caudillo-Ortega, N. A., Negrete‐Díaz, J. V., & Pérez‐Vázquez, V. (2024) · Revista Mexicana de Trastornos Alimentarios/Mexican Journal of Eating Disorders · doi:10.22201/fesi.20071523e.2024.1.707 · Cited by 1
Polizzi, A., Ruggieri, M., Praticò, A. D., Leotta, M., Cavallaro, P. A. R., Sciuto, L., Vecchio, M. M., & Napoli, C. D. (2024) · Journal of Pediatric Neurology · doi:10.1055/s-0044-1786784 · Cited by 1
Musco, N., Pascon, G., Addeo, N. F., Zarantoniello, M., Lanzieri, M., Olivotto, I., Tulli, F., Iervolino, V., Amato, R., Lombardi, P., et al. (2024) · Journal of Animal Science · doi:10.1093/jas/skae376 · Cited by 1
Brutlag, A. G. (2024) · Springer eBooks · doi:10.1007/978-3-031-67821-9_3 · Cited by 1
Marquez, J. D., Barbosa, G. C., Rodrigues, T. G., & de Carvalho, C. R. (2024) · VITTALLE - Revista de Ciências da Saúde · doi:10.63595/vittalle.v36i2.17275 · Cited by 1
“A ativação destes receptores suprime a liberação de alguns neurotransmissores e neuromoduladores (10).”
Salehi, M., Sedaghat, A., Bayanati, M., Rabbani, M. I. M., Rezaee, E., & Tabatabai, S. A. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11267-7 · Cited by 1
“A mixture of ben-zohydrazide [8] (1.36 g, 10 mmol) and cyanogen bromide (1.16 g, 11 mmol) was refluxed for 4 h in methanol under the fume hood.”
InfluentialFeki, O., Braham, I. Z., Haddar, S., Arfaoui, A., Errais, K., & Feki, M. (2025) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1177/10807683251368650 · Cited by 1
“Following synthesis, eCBs are transported across the membrane by a noncharacterized endocannabinoid membrane carrier 3,12 to bind to speci fi c receptors and undergo hydrolysis by intracellular degrading enzymes.”
Pieracci, Y., Russo, L., Ascrizzi, R., Basso, G., Bassolino, L., Giacomelli, C., Fulvio, F., Marchetti, L., Martini, C., Montanari, M., et al. (2026) · Waste and Biomass Valorization · doi:10.1007/s12649-026-03606-y · Cited by 1
“Increasing evidences suggest that the dysregulation of this system is implicated in numerous pathological conditions, especially neuroinflammation [14], a process marked by persistent microglial activation that promotes the release of pro-inflammatory cytokines, ultimately contributing to brain…”
Nagyova, A., & Hlaváčová, N. (2026) · Endocrine Regulations · doi:10.2478/enr-2026-0011 · Cited by 1
“Similarly, lipoxygenases and cytochrome P450 enzymes can generate bioactive oxidised derivatives of endocan-nabinoids with distinct biological activities (Kozak et al. 2002; Di Marzo et al. 2004).”
New Perspectives in Nuclear Neurology for the Evaluation of Parkinson's Disease
Benadiba, M., Luurtsema, G., Tumas, V., Buchpiguel, C. A., & Busatto, G. F. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130207 · Cited by 1
Pisanti, S. (2008) · Università degli Studi di Napoli Federico II · doi:10.6092/unina/fedoa/2627
Imming, P. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.12.003 · Cited by 1
Pagotto, U., Gambineri, A., Vicennati, V., & Pasquali, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_29 · Cited by 1
Botanical Compounds and Their Dermatologic and Cosmetic Uses
(2010) · Traditional herbal medicines for modern times · doi:10.1201/ebk1439812136-c2 · Cited by 1
Role of Endocannabinoids in Synaptic Plasticity and Memory ☆
Bura, S. A., Almada, R. C., Lutz, B., Marsicano, G., & Wotjak, C. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.02289-6 · Cited by 1
Pharmacologic Treatment of Obesity: Pitfalls and New Promises
Bermúdez, V., Rodríguez, M., Valdelamar, L., Luti, Y., Ciszek, A., Urdaneta, L., Guerra, X., Gotera, D., Colmenares, C., Chacín, M., et al. (2008) · Revista Latinoamericana de Hipertensión/Revista Latinoamericana de Hipertensiòn · Cited by 1
The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases
Coccurello, R., & Bisogno, T. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2016.1209111 · Cited by 1
“of DAergic innervation and facilitation of DA-evoked motor behavior [18,23].”
BackgroundUso medicinal de la marihuana: la discusión pendiente
Contreras‐Pulache, H. (2018) · ACTA MEDICA PERUANA · doi:10.35663/amp.2017.344.471 · Cited by 1
Modulation of endocannabinoid system: Success lies in the failures
Medhi, B., Kumar, S., Sarma, P., Kumar, H., & Prakash, A. (2018) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_541_18 · Cited by 1
Life cycle of scientific publications in the field of high social impact
Ruggiero, B., Amato, U., Franco, B., PETROCELLIS, L. D., Vettoliere, A., Granata, C., Silvestrini, S., Bonavolontà, C., Valentino, M., Brocchieri, J., et al. (2019) · Soft Computing · doi:10.1007/s00500-019-04441-1 · Cited by 1
Self-citationEndocannabinoidsystem und Stress: Mehr als nur ein „high“?
Spohrs, J., Martin, U., & Abler, B. (2021) · Nervenheilkunde · doi:10.1055/a-1301-3135 · Cited by 1
“[8] Di Marzo V, Bifulco M, De Petrocellis L.”
BackgroundChapter 16. Neurobiology of Marijuana
Sahlem, G. L., Sherman, B. J., & McRae‐Clark, A. L. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb16 · Cited by 1
Kong, L., Xiao, C., Lin, H., Buyse, J. G., Li, X., & Song, Z. (2021) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2021.111018 · Cited by 1
Brutlag, A. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-68317-7_3 · Cited by 1
Non‐Dopaminergic Approaches to the Treatment of Parkinson's Disease
Fox, S. H., & Brotchie, J. M. (2011) · Parkinson s Disease · doi:10.1002/9781444397970.ch38 · Cited by 1
Regulation of bone remodeling by central and peripheral nervous signals
Ducy, P. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00034-8 · Cited by 1
Koskinen, A. M. P. (2012) · Wiley eBooks · doi:10.1002/9781118347300.ch7 · Cited by 1
Liin, S. I. (2022) · The Journal of General Physiology · doi:10.1085/jgp.202213171 · Cited by 1
“AA, which is one of the most abundant PUFAs in the human body (Di Marzo et al., 2004), has a 20-carbon-long tail with 4 double bonds.”
BackgroundSultan, W., Mathew, A., Brown, M. R. D., Galvez-Florez, J. F., & Moreno‐Sanz, G. (2022) · Brain Sciences · doi:10.3390/brainsci12111467 · Cited by 1
“Cannabinoid receptors, endocannabinoids, and the enzymes involved in their synthesis and degradation comprise the endocannabinoid system (ECS), a functionally diverse regulator of many physiological processes which favours homeostasis [23].”
BackgroundOrg27569, the allosteric modulators and the cannabinoid receptor 1 (CB1)
Lu, D., & Glass, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90877-1.00015-2 · Cited by 1
Rare variant analysis for common diseases
Bhatia, G. (2009) · eScholarship (California Digital Library) · Cited by 1
Snider, N. T. (2009) · Deep Blue (University of Michigan) · Cited by 1
González‐Cuevas, G. (2011) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · Cited by 1
Central cannabinoid regulation of food intake in chickens
Zhang, J. (2005) · VTechWorks (Virginia Tech) · Cited by 1
Carriba, P. (2007) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
McCulloch, M., & Xu, Y. (2009) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826070903188179 · Cited by 1
Hagn, M. (2007) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.7090 · Cited by 1
O paracetamol mata? Hábitos de consumo na população portuguesa
Santos, D. B. D. A. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/0npf-n051 · Cited by 1
Pyrolytic Fate of Synthetic Cannabinoids
Nida, C. A. (2015) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.6316 · Cited by 1
Genomics of Adaptation and Diversification
Lynch, R. C. (2015) · CU Scholar (University of Colorado Boulder) · Cited by 1
Novel approaches in clinical development of cannabinoid drugs
Klumpers, L. E. (2014) · Leiden Repository (Leiden University) · Cited by 1
Manwell, L. A. (2013) · The Atrium (University of Guelph) · Cited by 1
Benton, M. C. (2014) · Griffith Research Online · doi:10.25904/1912/30 · Cited by 1
The effect of cannabidiol in the immature brain
Caulino‐Rocha, A. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/qd2h-gs13 · Cited by 1
The role of the endocannabinoid system in stress- and fear-related processes
Spohrs, J. (2021) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-36441 · Cited by 1
Edwards, A. (2014) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2014-10462 · Cited by 1
Endocannabinoids and their receptors modulate endometriosis pathogenesis and immune responsePreprint
Lingegowda, H., Zutautas, K. B., Wei, Y., Yolmo, P., Sisnett, D. J., McCallion, A., Koti, M., & Tayade, C. (2024) · eLife · doi:10.7554/elife.96523.2 · Cited by 1
Schachtsiek, J. (2019) · Technische Universität Dortmund Eldorado (Technische Universität Dortmund) · doi:10.17877/de290r-20468 · Cited by 1
Substâncias aditivas como factores de progressão na Hepatite C crónica
Ferreira, A. I. G. (2009) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/btp8-n288 · Cited by 1
Sutor, S. (2010) · University of Regensburg Publication Server (University of Regensburg) · Cited by 1
Acebal, L. R. (2012) · Communities in ADDI (University of the Basque Country) · Cited by 1
The role of endocannabinoid system in neuron-glial communication in the ageing and diseased brain
Ativie, F. (2017) · bonndoc (University of Bonn) · Cited by 1
Metabolik sendromlu hastalarda visfatin düzeyi
Yıldız, S. (2011) · DSpace - Düzce (Duzce University) · Cited by 1
Laliberte, S. (2022) · The Atrium (University of Guelph) · Cited by 1
Kolgazi, M. (2013) · Marmara University Open Access System · Cited by 1
Metadata
- Authors
- Marzo, V. D., Bifulco, M., & Petrocellis, L. D.
- Affiliations
- Istituto di Chimica Biomolecolare (IT)
- Institute of Applied Science and Intelligent Systems (IT)
- University of Salerno (IT)
- Corresponding author
- Marzo, Vincenzo Di
- Venue
- Nature Reviews Drug Discovery
- Published
- 2004-09-01
- Volume
- 3
- Issue
- 9
- Pages
- 771-784
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2087674201
- Cited by
- 1,090
- References
- 161
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 61 · 2023: 48 · 2022: 43 · 2021: 44 · 2020: 49 · 2019: 43 · 2018: 35 · 2017: 41 · 2016: 28 · 2015: 42 · 2014: 38 · 2013: 48 · 2012: 42
- FWCI
- 8.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- endocannabinoid system, cannabinoid receptors, cannabinoid therapeutics, drug development, pathological conditions
- MeSH terms
- Animals, Cannabinoids, Cannabis, Clinical Trials as Topic, Enzymes, Humans, Drug Design, Signal Transduction, Receptors, Cannabinoid, Cannabinoid Receptor Modulators, Cannabinoid Receptor Agonists, Cannabinoid Receptor Antagonists, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.